Amphora Discovery

closed

Offers precision pathway-based drug discovery services, developing proprietary compounds for oncology and inflammation.

Launch date

Jan 2001

Employees

Durham North Carolina (HQ)

Date	Investors	Amount	Round
Sep 2001	Venrock ARCH Venture Partners OrbiMed Versant Ventures CalPERS CW Ventures	$35.0m	Series A
Dec 2002	Venrock MPM BioImpact ARCH Venture Partners	$12.5m	Series B
Jan 2004	Venrock 3i Group MPM BioImpact ARCH Venture Partners Versant Ventures	$12.9m	Series B
Dec 2004	Venrock 3i Group MPM BioImpact ARCH Venture Partners Versant Ventures Novartis Venture Fund	$20.0m	Series C
Jun 2005	Venrock 3i Group MPM BioImpact ARCH Venture Partners Novartis Venture Fund	$9.6m	Series D
Feb 2006	Venrock 3i Group MPM BioImpact ARCH Venture Partners Versant Ventures	$4.4m	Series E
Total Funding		€85.7m

Recent News about Amphora Discovery